ID   BRE1B_RAT               Reviewed;        1002 AA.
AC   Q8CJB9;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   29-MAY-2024, entry version 145.
DE   RecName: Full=E3 ubiquitin-protein ligase BRE1B;
DE            Short=BRE1-B;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:12121982};
DE   AltName: Full=RING finger protein 40;
DE   AltName: Full=RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};
DE   AltName: Full=Syntaxin-1-interacting RING finger protein;
DE            Short=Protein staring;
GN   Name=Rnf40; Synonyms=Bre1b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], POSSIBLE FUNCTION, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, AND POSSIBLE INTERACTION WITH STX1A.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=12121982; DOI=10.1074/jbc.m203300200;
RA   Chin L.-S., Vavalle J.P., Li L.;
RT   "Staring, a novel E3 ubiquitin-protein ligase that targets syntaxin 1 for
RT   degradation.";
RL   J. Biol. Chem. 277:35071-35079(2002).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-585 AND SER-586, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex
CC       that mediates monoubiquitination of 'Lys-120' of histone H2B
CC       (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It
CC       thereby plays a central role in histone code and gene regulation. The
CC       RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation
CC       with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with
CC       UBE2E1/UBCH are contradictory. Required for transcriptional activation
CC       of Hox genes. {ECO:0000250|UniProtKB:O75150}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:12121982};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the RNF20/40 complex (also known as BRE1 complex)
CC       probably composed of 2 copies of RNF20/BRE1A and 2 copies of
CC       RNF40/BRE1B. Interacts with UBE2E1/UBCH6. Interacts with RB1 and WAC
CC       (By similarity). May interact with STX1A.
CC       {ECO:0000250|UniProtKB:O75150}.
CC   -!- INTERACTION:
CC       Q8CJB9; P61265: Stx1b; NbExp=4; IntAct=EBI-6110162, EBI-2255905;
CC       Q8CJB9; O14933: UBE2L6; Xeno; NbExp=2; IntAct=EBI-6110162, EBI-2129974;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75150}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in brain, testis,
CC       heart, liver and kidney. Weakly expressed in lung, spleen and skeletal
CC       muscle (at protein level). {ECO:0000269|PubMed:12121982}.
CC   -!- SIMILARITY: Belongs to the BRE1 family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be cytoplasmic and membrane-
CC       associated and to mediate ubiquitination and subsequent degradation of
CC       STX1A. {ECO:0000305|PubMed:12121982}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF352815; AAN16401.1; -; mRNA.
DR   RefSeq; NP_703201.1; NM_153471.1.
DR   AlphaFoldDB; Q8CJB9; -.
DR   SMR; Q8CJB9; -.
DR   IntAct; Q8CJB9; 2.
DR   STRING; 10116.ENSRNOP00000025500; -.
DR   iPTMnet; Q8CJB9; -.
DR   PhosphoSitePlus; Q8CJB9; -.
DR   PaxDb; 10116-ENSRNOP00000025500; -.
DR   GeneID; 266712; -.
DR   KEGG; rno:266712; -.
DR   UCSC; RGD:628638; rat.
DR   AGR; RGD:628638; -.
DR   CTD; 9810; -.
DR   RGD; 628638; Rnf40.
DR   VEuPathDB; HostDB:ENSRNOG00000018840; -.
DR   eggNOG; KOG0978; Eukaryota.
DR   HOGENOM; CLU_002640_0_0_1; -.
DR   InParanoid; Q8CJB9; -.
DR   OrthoDB; 53681at2759; -.
DR   PhylomeDB; Q8CJB9; -.
DR   TreeFam; TF323183; -.
DR   BRENDA; 2.3.2.27; 5301.
DR   Reactome; R-RNO-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q8CJB9; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000018840; Expressed in thymus and 18 other cell types or tissues.
DR   GO; GO:0033503; C:HULC complex; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0000151; C:ubiquitin ligase complex; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0017075; F:syntaxin-1 binding; IPI:RGD.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IDA:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:RGD.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IDA:RGD.
DR   GO; GO:1902916; P:positive regulation of protein polyubiquitination; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:RGD.
DR   CDD; cd16815; RING-HC_RNF40; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR013956; E3_ubiquit_lig_Bre1.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR23163:SF4; E3 UBIQUITIN-PROTEIN LIGASE BRE1B; 1.
DR   PANTHER; PTHR23163; RING FINGER PROTEIN-RELATED; 1.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromatin regulator; Coiled coil; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..1002
FT                   /note="E3 ubiquitin-protein ligase BRE1B"
FT                   /id="PRO_0000055843"
FT   ZN_FING         949..988
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..32
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          120..148
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          520..562
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          579..652
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          55..91
FT                   /evidence="ECO:0000255"
FT   COILED          190..378
FT                   /evidence="ECO:0000255"
FT   COILED          438..526
FT                   /evidence="ECO:0000255"
FT   COILED          628..947
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        605..620
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        634..652
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         20
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U319"
FT   MOD_RES         42
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VTR2"
FT   MOD_RES         356
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VTR2"
FT   MOD_RES         518
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U319"
FT   MOD_RES         585
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         586
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        579
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75150"
FT   CROSSLNK        580
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75150"
SQ   SEQUENCE   1002 AA;  113841 MW;  EFF371C06B52D231 CRC64;
     MSGLSNKRAA GDGGSGPPEK KLNREEKTTT TLIEPIRLGG ISSTEEMDSK VLQFKNKKLA
     ERLEQRQACE DELRERIEKL EKRQATDDAT LLIVNRYWAQ LDETVEALLQ CYENQRELSS
     SGTEVPGCQE GLTRDVIPRT DPGTSDLREP LPMQFRAPLS EPALAFVVAL GASSCEEVEL
     QLQGRMEFSK AAVSRVVEAS DRLQRQVEEL CQRVYSRGDS EAPGEVARAR TRELGRENRR
     LQDLATQLQE KHHRISLEYS ELQDKVTSTE TKVLEMETTV EDLQWDIEKL RKREQKLNKH
     LAEALEQLNS GYYVSGSSTG FQGGQITLSM QKFEMLNAEL EENQELANSR MAELEKLQAE
     LQGAVRTNER LKVALRSLPE EVVRETGEYR MLQAQFSLLY NESLQVKTQL DEARGLLLAS
     KNSHLRHIEH MESDELGLQK KLRTEVIQLE DTLAQVRKEY EMLRIEFEQN LAANEQAGPI
     NREMRHLISS LQNHNHQLKG DAQRYKRKLR EVQAEIGKLR AQASGSSHCG PNLSHPDDSG
     LNALAPGKED SGPGPGGTPD SKKELALVAG ATSVASSVKK EELVSSEDDA QALAPGTQGL
     PSRGREPEAR PKRELREREG PSLGPPPAAS TLSRADREKA KAEEARRKES ELLKGLRAEL
     KKAQESQKEM KLLLDMYKSA PKEQRDKVQL MAAERKAKAE VDELRSRIRD LEERDRRESK
     KIADEDALRR IRQAEEQIEH LQRKLGATKQ EEEALLSEMD VTGQAFEDMQ EQNGRLLQQL
     REKDDANFKL MSERIKANQI HKLLREEKDE LGEQVLGLKS QVDAQLLTVQ KLEEKERALQ
     GSLGGVEKEL TLRSQALELN KRKAVEAAQL AEDLKVQLEH VQTRLREIQP CLAESRAARE
     KESFNLKRAQ EDISRLRRKL EKQRKVEVYA DADEILQEEI KEYKARLTCP CCNTRKKDAV
     LTKCFHVFCF ECVRGRYEAR QRKCPKCNAA FGAHDFHRVY IS
//
